This country profile provides an overview of the Congo’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
52%
Blinding trachoma
N/A
Intestinal worms
47%
Bilharzia
0%
River blindness
82%
877k
people received treatment in the Congo in 2019
530k
people did not receive treatment in the Congo in 2019
Elephantiasis
Treatment coverage increased from 30% in 2018 to 52% in 2019.
People needing treatment
1.03
People receiving treatment
532k
Blinding trachoma
Congo does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage increased from 43% in 2018 to 47% in 2019.
Pre-sch and school-aged children needing treatment
809k
Pre-school and school-aged children receiving treatment
378k
Bilharzia
Treatment coverage decreased from 37% in 2018 to 0% in 2019.
School-aged children needing treatment
219k
School-aged children receiving treatment
Zero
River blindness
Treatment coverage increased from 81% in 2018 to 82% in 2019.
People needing treatment
714k
People receiving treatment
582k
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Congo.